What you should know:
1. Mr. Kenny will be responsible for leading the global spine implants, motion preservation, bone growth therapies and biologics businesses.
2. At Medtronic, Mr. Kenny oversaw 1,500 direct and nondirect sales personnel over a nine-year period.
3. Mr. Kenny most recently served as COO at Cardiovascular Systems, where he developed and commercialized new products worldwide.
4. He also held positions at Bausch and Lomb and B.Braun/McGaw.
More articles on devices:
Johnson & Johnson subsidiary launches product for surgical bleeding: 5 things to know
Stanford to acquire 2nd CyberKnife M6 system for neurosurgery
Andrews to expand with new clinical location — 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
